Here is a data-driven look at Syngene (SYNGENE), covering financial performance, valuation, and shareholding trends.
Syngene Revenue Trend
At ₹3,714 Cr, Syngene's FY2025 revenue was 3.8% ahead of the ₹3,579 Cr posted in FY2024.
The bigger picture is compelling: a 15.8% annual growth rate over 10 years took revenue from ₹860 Cr to ₹3,714 Cr.
With a top line of ₹3,714 Cr, Syngene operates at a mid-sized scale within the miscellaneous sector.
Revenue has moved in the same direction for 10 years running, suggesting the growth trend has structural legs.
| Year | Revenue | YoY % |
|---|---|---|
| FY2025 | ₹3,714 Cr | +3.8% |
| FY2024 | ₹3,579 Cr | +9.7% |
| FY2023 | ₹3,264 Cr | +22.8% |
| FY2022 | ₹2,657 Cr | +18.1% |
| FY2021 | ₹2,249 Cr | — |
View Syngene's full 10-year revenue trend with CAGR analysis →
Syngene Profitability
The bottom line took a hit: Syngene's net profit slipped 2.7% to ₹496 Cr in FY2025.
Margins came under pressure in FY2025, with net profit margin dropping to 13.4% from 14.2%.
At ₹12.34 per share (diluted), FY2025 earnings were down year-over-year from ₹12.69.
Is Syngene Undervalued
The P/E Ratio valuation pegs Syngene's fair value at ₹720, which is 64.4% upside from the current price.
Syngene shares are currently trading at ₹438.10.
Craytheon also calculates intrinsic value using the EPS Growth and DCF models. The full breakdown with assumptions is available in the detailed analysis.
| Model | Est. Fair Value | vs. Current Price |
|---|---|---|
| P/E Ratio | ₹720 | 64.4% upside to fair value |
| EPS Growth | Upgrade | Upgrade |
| DCF | Upgrade | Upgrade |
See all valuation models for Syngene with detailed assumptions →
Syngene Shareholding Pattern
At 52.7%, the promoter stake has been flat for the past 4 quarters.
On the foreign institutional side, the holding is 13.9% as of March 2026 — down from 16.5%.
The DII stake stands at 26.4% as of March 2026, versus 24.1% in the year-ago period.
| Quarter | Promoter | FII | DII | Public |
|---|---|---|---|---|
| Mar 2026 | 52.7% | 13.9% | 26.4% | 6.7% |
| Dec 2025 | 52.7% | 15.0% | 25.8% | 6.2% |
| Sep 2025 | 52.7% | 16.3% | 24.6% | 6.1% |
| Jun 2025 | 52.7% | 16.5% | 24.1% | 6.5% |
Track quarterly shareholding changes for Syngene →
Syngene Balance Sheet
Proportional view as of 3 Jun 2026. Hover blocks for details.
Assets
Liabilities & Equity
FY2025 total assets: ₹67.96B (up 10.5% YoY from ₹61.52B).
Top categories: Property, Plant & Equipment (52.7%), Other Assets (19.4%), Cash & ST Investments (14.4%).
Of the ₹67.96B in liabilities and equity, 69.6% is shareholder equity, 8.5% is interest-bearing debt, and 21.9% is operating liabilities. Over the year, debt is up 4.1% and equity is up 11.0%.
Balance sheet composition — FY 2025
| Category | Value |
|---|---|
| Cash & ST Investments | 9.78B |
| Receivables | 5.27B |
| Inventories | 1.56B |
| Property, Plant & Equipment | 35.84B |
| Investments | 2.07B |
| Intangibles & Goodwill | 256.00M |
| Other Assets | 13.20B |
| Category | Value |
|---|---|
| Equity | 47.27B |
| Short-term Debt | 1.69B |
| Long-term Debt | 4.09B |
| Trade Payables | 3.52B |
| Other Liabilities | 11.39B |
Syngene — The Bottom Line
What should investors take away from Syngene's (SYNGENE) latest numbers? Here's the summary.
Revenue of ₹3,714 Cr in FY2025, up 3.8% year-over-year.
Long-term revenue has been compounding at 15.8% annually over 10 years.
The company is profitable, with a net margin of 13.4% and net income of ₹496 Cr.
The P/E Ratio model implies 64.4% upside to fair value from the current price. The remaining two models are worth cross-checking before drawing a conclusion — sign up to see the full analysis.
Unlock Full Analysis
For the complete 10-year financial history with interactive charts and growth analysis, explore Syngene's detailed profile on Craytheon.